Clinical trials for CLL & Richter's syndrome

41 currently recruiting clinical trials

Phase 2 CLL & Richter's syndrome #NCT04728893 #2023-504931-42-00
Required histologic types
Richter's syndrome
Required central nervous system lesions
None Treated / Controled
Required number of previous lines of therapy
1 2 3 or more
Excluded previous treatments
Systemic Treatment-Naive
5 recruiting sites
Merck Sharp & Dohme LLC
Phase 2 CLL & Richter's syndrome #NCT05963074 #2023-504044-34-00
Required histologic types
CLL (Chronic Lymphocytic Leukemia)
Required central nervous system lesions
None
Required number of previous lines of therapy
None
Required previous treatments
Systemic Treatment-Naive
5 recruiting sites
Janssen
Phase 2 CLL & Richter's syndrome #NCT06588478 #2024-515689-15-01
Required histologic types
CLL (Chronic Lymphocytic Leukemia)
Required number of previous lines of therapy
1 2 3 or more
Required previous treatments
Targeted therapy
Excluded previous treatments
Systemic Treatment-Naive
6 recruiting sites
Loxo Oncology
Phase 2 Lymphoma CLL & Richter's syndrome #NCT04728893 #2023-504931-42-00
Required histologic types
B cell lymphoma CLL (Chronic Lymphocytic Leukemia)
Required histologic sub types
Lymphocytic lymphoma
Required central nervous system lesions
None Treated / Controled
Required number of previous lines of therapy
1 2 3 or more
Excluded previous treatments
Systemic Treatment-Naive
5 recruiting sites
Merck Sharp & Dohme LLC
Phase 2 CLL & Richter's syndrome #NCT06588478 #2024-515689-15-01
Required histologic types
CLL (Chronic Lymphocytic Leukemia)
Required number of previous lines of therapy
None
Required previous treatments
Systemic Treatment-Naive
6 recruiting sites
Loxo Oncology
Phase 1 / Phase 2 Lymphoma CLL & Richter's syndrome Acute leukemia Myelodysplastic Syndromes (MDS) and Myeloproliferative Neoplasms (MPN) #NCT07220616 #2025-522595-87-00
Required central nervous system lesions
None Treated / Controled
Required number of previous lines of therapy
1 2 3 or more
Excluded previous treatments
Systemic Treatment-Naive Allogeneic stem cell transplant
3 recruiting sites
Daiichi Sankyo
Phase 1 / Phase 2 Lymphoma CLL & Richter's syndrome #NCT05006716
Required histologic types
B cell lymphoma CLL (Chronic Lymphocytic Leukemia) Richter's syndrome
Required histologic sub types
Large B cell lymphoma Mantel cell lymphoma Follicular lymphoma Marginal zone lymphoma Waldenström lymphoma Lymphocytic lymphoma
Required central nervous system lesions
None
Required number of previous lines of therapy
1 2 3 or more
Excluded previous treatments
Systemic Treatment-Naive
9 recruiting sites
BeOne Medecines
Phase 1 / Phase 2 Lymphoma CLL & Richter's syndrome #NCT06564038 #2024-515034-33-00
Required histologic types
B cell lymphoma CLL (Chronic Lymphocytic Leukemia)
Required histologic sub types
Lymphocytic lymphoma
Required number of previous lines of therapy
1 2 3 or more
Required previous treatments
Targeted therapy
Excluded previous treatments
Systemic Treatment-Naive
4 recruiting sites
AstraZeneca
Phase 1 / Phase 2 Lymphoma CLL & Richter's syndrome #NCT06564038 #2024-515034-33-00
Required histologic types
B cell lymphoma CLL (Chronic Lymphocytic Leukemia)
Required histologic sub types
Lymphocytic lymphoma
Required number of previous lines of therapy
2 3 or more
Excluded previous treatments
Systemic Treatment-Naive
4 recruiting sites
AstraZeneca
Phase 1 / Phase 2 Lymphoma CLL & Richter's syndrome Acute leukemia #NCT04707300 #2019-004883-23
Required histologic types
CLL (Chronic Lymphocytic Leukemia) Acute lymphoblastic leukemia (ALL) Acute myeloid leukemia (AML)
4 recruiting sites
Assistance Publique - Hôpitaux de Paris